Sinofn Health
Sinofn Health
The Paris market represents one of the most sophisticated landscapes for Foods for Special Medical Purposes (FSMP). As the French healthcare system prioritizes chronic disease management and geriatric health, the demand for high-quality, clinically validated nutritional interventions is surging. SINOFN provides a bridge between advanced biomanufacturing capabilities and the rigorous quality expectations of European health agencies.
Navigating the EU market requires strict adherence to Regulation (EU) No 609/2013. SINOFN specializes in "Regulatory-First" formulation, ensuring that every product batch meets the specific labeling, ingredient purity, and safety profile mandated by French health authorities. We provide full traceability—from raw material sourcing to final logistics in Paris.
Our R&D department, in partnership with the Chinese Academy of Sciences, is currently focusing on "Precision Nutrition." This includes bio-available delivery systems for patients with metabolic disorders, customized microbiome support, and clean-label plant-based protein structures for clinical recovery.
Founded in 2012, backed by the Chinese Academy of Sciences, we are not just a manufacturer; we are a partner in medical innovation. With a 53,000 sqm facility, 25+ patents, and a dedicated team of researchers led by Dr. Zhang Ying, we provide the technical foundation for your brand's success.
Yes, we provide comprehensive documentation, including stability studies and nutritional profiles, tailored to satisfy EU regulatory bodies and French health agencies.
We offer flexible scalability, supporting both pilot runs for startups and high-volume industrial production for established pharmacy chains.
Our facility is FSSC 22000, ISO 22000, and HACCP certified. Every batch undergoes rigorous HPLC/GC-MS testing to ensure compliance with European safety standards.
